HepyC.01032.a
Tyrosine--tRNA ligase (EC 6.1.1.1) (Tyrosyl-tRNA synthetase)
CENTER ID:
HepyC.01032.a
ORGANISM:
Helicobacter pylori G27
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
I
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
HepyC.01032.a.B1.GE40952
full length
info
1
402
HepyC.01032.a.B1.GE40952
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
HepyC.01032.a.B1.PS38283
full length
info
1
402
PS38283
HepyC.01032.a.B1.PW38234
full length
info
1
402
PW38234
HepyC.01032.a.B1.PW38235
full length
info
1
402
PW38235
Structures
6BYQ
DEPOSITED: 12/21/2017
DETERMINATION: XRay
CLONE: HepyC.01032.a.B1.GE40952
PROTEIN: HepyC.01032.a.B1.PS38283
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MEQKISVALK EIKRGANEII GLEYIEKLVR KYYETNERFI VKAGFDPTAP DLHLGHTVLI QKLALLQQYG ARVKFLIGDF TAMIGDPTGK NETRKPLNRE QVLENAKTYE EQIYKILDQK HTEVCFNSTW LDALGAKGMI ELCAKFSVAR MLERDDFAKR HKENRPISIV EFLYPLLQGY DSVAMGADIE LGGNDQKFNL LVGRFLQRAY GLNKEQSIIT MPLLEGLDGV QKMSKSLGNY VGITEEPNAM FGKIMSVSDD LMWRYYTLLS AKTLEEIEDL KHGILNQTLH PKAVKEDLAG EIVARYYDND QAFKAKEQFS KVFSANLLPE ILSESDFDEG VGILDVLKQI GFCPSTSQAR RDIQGGGVKI NQEVIKDESY RFVKGNYVIQ LGKKRFMKLN IN
NT Sequence
atggaacaaa aaatcagtgt ggccttaaaa gagatcaaaa gaggtgctaa tgaaatcatt ggattagaat acattgaaaa gctggtgagg aaatattatg aaaccaatga acgctttatc gttaaagccg gttttgatcc taccgctccc gatttgcatt tagggcatac ggtgttgatc caaaaattgg ctttgttgca gcaatatggg gctagggtta agtttttgat tggggatttt accgctatga taggcgatcc tacgggtaag aatgaaacga gaaaaccctt aaaccgggag caagtcttag aaaacgctaa aacttatgaa gagcaaatct ataagatttt agatcaaaaa cacaccgaag tgtgctttaa ttccacttgg ttggatgctt taggcgcaaa gggcatgata gaattgtgcg cgaagttttc agtcgctaga atgttagaaa gggacgattt tgctaaacgc cataaagaaa accgccccat tagcatcgtg gaatttttat accctttgtt gcaaggctat gattcagtgg cgatgggtgc ggatattgag cttgggggca atgatcaaaa gtttaatttg ctggtggggc gctttttgca acgagcttat ggcttgaata aagagcagtc tattattacc atgcctttat tagaagggct tgatggggtg caaaaaatga gtaaaagctt ggggaattat gtggggatca ctgaagagcc taatgcgatg tttgggaaga tcatgagcgt gagcgatgat ctcatgtggc gctactacac ccttttgagc gctaagactt tagaagaaat tgaagactta aaacatggta ttttaaacca aaccttgcac cctaaagccg ttaaagagga tctcgctggt gaaatcgtgg ctcgttatta tgataatgat caagcattca aggctaaaga gcaattttct aaagtgttta gcgcaaacct tttgcctgaa attttatcag agagcgattt tgatgaaggg gttgggattt tagatgtttt aaaacagatt ggcttttgcc catccacttc acaagccagg cgtgatattc aagggggagg ggtaaagatt aatcaagaag tgataaaaga tgagagttat cgttttgtta aaggaaatta tgttatacag cttggtaaga aaagatttat gaaattaaat atcaactaa
Details for HepyC.01032.a.B1.GE40952
HARVESTED ON:
12/20/2016
SEQUENCED ON:
12/27/2016
EXPECTED MW:
47kDa
OBSERVED MW:
47kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Many (50-100)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
98
PERCENT COVERAGE:
97
Details for HepyC.01032.a.B1.PS38283
PURIFICATION DATe:
5/9/2017
CONCENTRATION:
56.53mg/ml
OBSERVED MW:
45kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
SEC: 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
7
VIAL VOLUME:
200µl
PERCENT IDENTITY:
98
PERCENT COVERAGE:
97
Details for HepyC.01032.a.B1.PW38234
PURIFICATION DATe:
3/27/2017
CONCENTRATION:
37mg/ml
OBSERVED MW:
47kDa
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 8.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
2
VIAL VOLUME:
200µl
PERCENT IDENTITY:
98
PERCENT COVERAGE:
97
Details for HepyC.01032.a.B1.PW38235
PURIFICATION DATe:
3/27/2017
CONCENTRATION:
27mg/ml
OBSERVED MW:
47kDa
EXPRESSION LEVEL:
High Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 8.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
3
VIAL VOLUME:
110µl
PERCENT IDENTITY:
98
PERCENT COVERAGE:
97